P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 226,866 shares at $175.19 ($39.7M) on 2012-11-27, disclosed to the SEC on 2012-11-27.
Scheduled sale ($39.7M) by Chairman of the Board under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.00 | 34,696 | $6.1M | 15.3% |
| 2 | $175.00 | 127,417 | $22.3M | 56.1% |
| 3 | $175.12 | 28,507 | $5.0M | 12.6% |
| 4 | $175.19 | 32,356 | $5.7M | 14.3% |
| 5 | $176.18 | 3,890 | $685K | 1.7% |
| Total | $175.06 avg |
| 226,866 |
| $39.7M |
| 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |